MedPath

Effect of symbiotic on Allergic Rhinitis

Phase 3
Conditions
Perennial allergic rhinitis.
Other allergic rhinitis
Registration Number
IRCT2017061223235N11
Lead Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

patients with persistent allergic rhinitis; Mashhad residents and surrounding towns; Have a positive skin test with Aeroallergen; Cooperate in projects Exclusion criteria: A history of autoimmune disease; Systemic corticosteroids or immunosuppressive drugs consumption and effective on immune system; Pregnant Women; Patients with immunodeficiency; Patients with malnutrition; Use Antibiotic during synbiotic consumption

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gene expression of FoxP3,TGF-ß,IL-17,IL-10,IL-4,IFN-?. Timepoint: Before intervention, after 2 month, after 6 month. Method of measurement: Real Time-PCR.;Quality of life. Timepoint: Before intervention, after 2 month, after 6 month. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
Systemic reactions to immunotherapy. Timepoint: At every turn immunotherapy. Method of measurement: Clinical.
© Copyright 2025. All Rights Reserved by MedPath